RENAISSANCE TECHNOLOGIES LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1037389
NEW YORK, NY
Position in GLUE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,480,500
-$3,755,695 QoQ
Shares Held
102,500
-73.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 193 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. GLUE ranks #118 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in GLUE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,480,500 | 102,500 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,236,195 | 379,100 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $2,932,381 | 395,733 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,774,101 | 615,100 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $761,424 | 164,100 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,705,158 | 245,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,159,110 | 218,700 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $952,630 | 254,714 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $860,805 | 122,100 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $594,380 | 105,200 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $438,285 | 91,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $560,330 | 81,800 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $217,341 | 27,900 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $124,804 | 16,400 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||